EE282 Cost-Equalization Approach to Estimate the Minimum Duration of Effect of Cell and Gene Therapies to Demonstrate Cost Savings to Payors: A Methodological Approach Using Late-Onset Pompe Disease
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.581
https://www.valueinhealthjournal.com/article/S1098-3015(24)00696-X/fulltext
Title :
EE282 Cost-Equalization Approach to Estimate the Minimum Duration of Effect of Cell and Gene Therapies to Demonstrate Cost Savings to Payors: A Methodological Approach Using Late-Onset Pompe Disease
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00696-X&doi=10.1016/j.jval.2024.03.581
First page :
Section Title :
Open access? :
No
Section Order :
10056